Safety of live attenuated herpes zoster vaccine in Australian adults 70–79 years of age: an observational study using active surveillance

Analysis of data from adults 70–79 yrs vaccinated with live attenuated HZ vaccine, who responded to a survey (n=17,804), found it had a good short-term safety profile. Similar participant-based surveillance will be used as part of COVID-19 vaccine safety surveillance in Australia

Source:

BMJ Open